You can confirm your states Medicaid formulary to see whether it provides coverage for semaglutide
Semaglutide reduces cardiovascular risk independent of weight loss , with similar cardiovascular benefits observed in patients who did not lose weight compared to those who did
Preventing joint injuries through balance training, fall prevention, and appropriate footwear is especially important in older adults. Managing metabolic health conditions such as diabetes and insulin resistance may also reduce osteoarthritis risk by limiting systemic inflammatory and metabolic stress on joint tissues, Baker said
Together, these effects normalize blood sugar without a significant risk of low blood sugar levels and help with weight loss in people with type 2 diabetes
Tirzepatide is a dual GIP/GLP-1 receptor co-agonist that produced 22.5% mean body-weight reduction at 72 weeks on the 15 mg arm in SURMOUNT-1 (Jastreboff et al., NEJM, 2022), versus 2.4% on placebo